PTCT has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.
Insider Trading Summary & Commentary
Automated executive transaction analysis for PTCT
Over the last 90 days, corporate insiders at PTCT (PTCT) engaged in a total of 63 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 1 were sales. The total volume of insider trading reached $149K.
The net insider activity for PTCT shows a net selling bias of $149K. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Schmertzler Michael (Dir), who traded 2.5K shares valued at $149K on Oct 14, 2026.
Live Market News & Developments
Aggregated real-time headlines for PTCT (PTCT)
6 updates
PTC Therapeutics, Inc. (PTCT) Stock Price, News, Quote & History
Yahoo! Finance CanadaYesterday
Ptc Therapeutics Stock Price Forecast. Should You Buy PTCT?
StockInvest.us3d ago
PTC Therapeutics, Inc. (PTCT) Stock Forecasts
Yahoo Finance16h ago
After exercising options at $25.69 a share, PTC Therapeutics (PTCT) legal chief Boulding sold 2,812 shares.
Stock TitanYesterday
PTC Therapeutics (NASDAQ:PTCT) Reaches New 12-Month Low on Insider Selling
MarketBeat11h ago
PTC Therapeutics exec. VP and CLO sells $174K in shares By Investing.com
Investing.com IndiaYesterday
FAQs About PTCT Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for PTCT.
Based on SEC Form 4 disclosures, the Insider Confidence Score for PTCT is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 1 sales by company executives over the last 90 days.
The CEO Conviction Index for PTCT is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.
No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.